[PEARW] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[PEARW] Pear Therapeutics, Inc.
Announcement Date
31-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 182.80%
YoY- 131.37%
Quarter Report
PEARW's Result
PEARW's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 2,565 4,083 3,297 2,749 4,208 0 0 -
PBT -26,371 -30,723 5,462 -23,859 -65,142 5,832 -9,264 100.47%
Tax -55,198 4,094 -38,282 -10,882 26,764 0 0 -
NP 28,827 -34,817 43,744 -12,977 -91,906 5,832 -9,264 -
Tax Rate - - 700.88% - - 0.00% - -
Total Cost -26,262 38,900 -40,447 15,726 96,114 -5,832 9,264 -
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 1,123.86 -852.73 1,326.78 -472.06 -2,184.08 0.00 0.00 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS 0.21 -0.25 0.30 -0.09 -0.67 0.21 -0.34 -
EPS Diluted 0.21 -0.25 0.30 -0.09 -0.67 0.85 -1.34 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.